115 1 BLA 125742 0 08 21 2021 Telecon Labeling via FAX e

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

1

Document text

From:  Gottschalk, Laura  
Sent:  Saturday, August 21, 2021 11:11 AM  
To: Harkins Tull, Elisa <[email protected]>  
Cc: Devlin, Carmel M <[email protected]>; Aghajani Memar, Neda 
<[email protected]>; Smith, Michael (CBER) <[email protected]>; Naik, 
Ramachandra <[email protected]>  
Subject:  STN 125742/0 - Final Draft Labels: Carton and Containers  
 Dear Ms. Harkins,  
 
We have reviewed your draft Carton and Container labels submitted in Amendment 63 to your BLA, dated August 19, 2021 (STN 125742/0.63; Seq 0064) and found them to be acceptable. CBER considers the Carton and Container labels included in Amendment 63 as the Final Draft Labels for approval.   
Best regards,  
Laura  
 
Laura Gottschalk, PhD  
Regulatory Project Manager/Primary Reviewer    
Center for Biologics Evaluation and Research  
Office of Vaccines Research and Review  
U.S. Food and Drug Administration 
Tel: 301 -796- 0798 
[email protected]  
 
 
         
 
THIS MESSAGE IS INTENDED ONLY FOR THE USE OF THE PARTY TO WHOM IT IS ADDRESSED AND MAY CONTAIN INFORMATION THAT IS PRIVILEGED, CONFIDENTIAL, AND PROTECTED FROM DISCLOSURE UNDER LAW.   If you are not 
the addressee, or a person authorized to deliver the document to the addressee, you are hereby notified that any review, disclosure, dissemination, copying, or other action based on the content of this communication is not authorized.   If you 
have received this document in error, please immediately notify the sender by e- mail or phone.  
 
 
FDA-CBER-2021-5683-1150342